Suven Life Sciences Statistics

Total Valuation

BOM:530239 has a market cap or net worth of INR 64.88 billion. The enterprise value is 64.28 billion.

Market Cap	64.88B
Enterprise Value	64.28B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BOM:530239 has 218.07 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	218.07M
Shares Outstanding	218.07M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	-0.45%
Owned by Insiders (%)	2.08%
Owned by Institutions (%)	6.91%
Float	61.58M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	974.74
PB Ratio	58.99
P/TBV Ratio	59.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-39.99
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-33.59

Financial Position

The company has a current ratio of 3.21

Current Ratio	3.21
Quick Ratio	2.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,682.30

Financial Efficiency

Return on equity (ROE) is -84.60% and return on invested capital (ROIC) is -56.34%.

Return on Equity (ROE)	-84.60%
Return on Assets (ROA)	-51.06%
Return on Invested Capital (ROIC)	-56.34%
Return on Capital Employed (ROCE)	-153.63%
Revenue Per Employee	472,043
Profits Per Employee	-11.40M
Employee Count	141
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +107.84% in the last 52 weeks. The beta is 0.78, so BOM:530239's price volatility has been lower than the market average.

Beta (5Y)	0.78
52-Week Price Change	+107.84%
50-Day Moving Average	224.68
200-Day Moving Average	152.19
Relative Strength Index (RSI)	71.58
Average Volume (20 Days)	27,149

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:530239 had revenue of INR 66.56 million and -1.61 billion in losses. Loss per share was -7.37.

Revenue	66.56M
Gross Profit	66.56M
Operating Income	-1.72B
Pretax Income	-1.61B
Net Income	-1.61B
EBITDA	-1.66B
EBIT	-1.72B
Loss Per Share	-7.37

Full Income Statement

Balance Sheet

The company has 600.05 million in cash and n/a in debt, giving a net cash position of 600.05 million or 2.75 per share.

Cash & Cash Equivalents	600.05M
Total Debt	n/a
Net Cash	600.05M
Net Cash Per Share	2.75
Equity (Book Value)	1.10B
Book Value Per Share	5.06
Working Capital	519.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.54 billion and capital expenditures -372.76 million, giving a free cash flow of -1.91 billion.

Operating Cash Flow	-1.54B
Capital Expenditures	-372.76M
Free Cash Flow	-1.91B
FCF Per Share	-8.78

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,578.13%
Pretax Margin	-2,415.11%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOM:530239 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	n/a
Earnings Yield	-2.48%
FCF Yield	-2.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 23, 2007. It was a forward split with a ratio of 4.

Last Split Date	Mar 23, 2007
Split Type	Forward
Split Ratio	4

Scores

Altman Z-Score	n/a
Piotroski F-Score	2